MedTrace Logo

Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

NCT00309751 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 418

Last updated 2010-02-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the efficacy and safety of pitavastatin with that of atorvastatin in patients with type II diabetes mellitus (type II DM) and combined dyslipidemia.

Conditions

Interventions

DRUG

Pitavastatin

Pitavastatin 4 mg QD

DRUG

Atorvastatin

Atorvastatin 20 mg

Sponsors & Collaborators

  • Kowa Research Europe

    lead INDUSTRY

Principal Investigators

  • Dragos Budinski, Med Dr. · Kowa Research Europe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • Denmark
  • Germany
  • India
  • Netherlands
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00309751 on ClinicalTrials.gov